OPARIL SUZANNE 4
4 · ENCYSIVE PHARMACEUTICALS INC · Filed Jul 1, 2005
Insider Transaction Report
Form 4
OPARIL SUZANNE
Director
Transactions
- Other
Common Stock
2005-06-30$10.95/sh+684$7,490→ 16,376 total
Footnotes (1)
- [F1]Common Stock issued in lieu of Board of Directors fees.